Kelly Wilkicki, M.P.P., is the Senior Advisor for Innovation in the Office of Strategic Partnerships and Technology Innovation (OST), in the Center for Devices and Radiological Health (CDRH)/FDA.
Kelly Wilkicki, M.P.P., is the Senior Advisor for Innovation in the Office of Strategic Partnerships and Technology Innovation (OST), in the Center for Devices and Radiological Health (CDRH)/FDA. In this role, Ms. Wilkicki works to address barriers to patient access to medical devices.
Prior joining OST in 2015, Ms. Wilkicki was a Policy Analyst in the Office of In Vitro Diagnostics and Radiological Health (OIR) in CDRH/FDA where she managed the Premarket Approval (PMA) and Humanitarian Device Exemption (HDE) programs for high-risk medical devices.
In 2008, Ms. Wilkicki began her career in the federal government as a Presidential Management Fellow (PMF) in the Office of the Commissioner/FDA. While employed in the Office of the Commissioner, Ms. Wilkicki was instrumental in organizing and implementing the Commissioner’s Fellowship Program. Also during her time as a PMF, she completed a seven month rotation to Congressional Research Services, Domestic Policy Division where she contributed to health reform legislative efforts, focusing on Medicare, Medicaid, and CHIP Programs.
Ms. Wilkicki received her Masters in Public Policy from The Johns Hopkins University in 2008, with a concentration in Health Policy. Ms. Wilkicki also received a certificate in Health Finance and Management and a certificate in Health Policy from the Johns Hopkins Bloomberg School of Public Health. She completed her undergraduate studies at Boston University where she majored in Biology, and minored in Philosophy.
Senior Advisor for Innovation in the Office of Strategic Partnerships and Technology Innovation